The House of Representatives has passed legislation that would increase government oversight of pharmaceutical manufacturing and distribution. One provision establishes nationwide rules to identify stolen or counterfeit drugs through new record-keeping requirements and notification rules for unsafe medicines. The second gives the FDA greater authority to regulate compounding pharmacies that produce sterile drugs and ship them across state lines.

Full Story:
Reuters, Bloomberg

Related Summaries